Loading...
Contemporary therapeutics and new drug developments for treatment of Fabry disease: a narrative review
Fabry disease (OMIM 301500) is an X-linked (Xq22.1) lysosomal storage disorder leading to a progressive multisystem disease with high variability in both genotype and phenotype expression. The pathophysiological origin is found in an enzyme deficiency of the α-galactosidase A (enzyme commission no....
Saved in:
| Published in: | Cardiovasc Diagn Ther |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8102271/ https://ncbi.nlm.nih.gov/pubmed/33968645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/cdt-20-743 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|